Mitigate the Indirect Impact of Regulations On your Bottom Line
CHAPEL HILL, N.C., Dec. 02, 2021/PRNewswire/ -- With the complexities of global regulations placing a strain on the operational costs for both quality and regulatory operations, being aware of expected maintenance costs for complying with regulations becomes increasingly important.
According to Best Practices Research, the majority of companies who have significant presence in the EU spend between 2% and 4.9% of their budget on maintenance costs for EUMDR compliance.
The study probes the real-world costs and challenges that companies are experiencing during this transition from MDD/AIMD to MDR - and some of the effective ways in which they are responding to these challenges.
“Navigating the Challenges and Costs of the New European Union Medical Device Regulation (EUMDR)”
is a 60-page study that examines:
- EUMDR Implementation Costs Analysis
- Regulatory Class + Company Size Influence
- EU Revenue Influence on Cost
- Product Risk, TA / Condition Influence on Cost
- Activities & Cost Drivers Drill Down Analysis
For this research, Best Practices, LLC engaged executives from 25 medical device companies across 15 therapeutic areas. More than ninety percent of the respondents served at a director or VP level or above.
For more data regarding costs related to regulation compliance, download a complimentary report excerpt at https://www.best-in-class.com/rw144.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.